Operations Readiness

PGx Laboratory Certification & Compliance Checklist

Everything a direct-to-consumer pharmacogenomic testing operation must have in place — from CLIA certification through genetic consent, physician ordering, and test validation — before accepting its first paying customer. Tap any item to mark it complete.

CLIA

Clinical Laboratory Improvement Amendments

CMS · CDC

CAP

Laboratory Accreditation

College of American Pathologists

COLA

Clinical Lab Accreditation

Accreditation Commission

HIPAA

Health Privacy & Security

HHS · OCR

FDA

LDT / IVD Oversight

U.S. Food & Drug Administration

NextGen PGx is pursuing the certifications above. These logos identify the regulatory and accreditation bodies whose requirements this checklist tracks — they do not imply current accreditation.

1. CLIA Certification

0 of 5 complete

A valid CLIA certificate is legally required before performing and reporting human testing.

2. Accreditation — CAP and/or COLA

0 of 5 complete

Private accreditation provides CMS 'deemed status' and signals quality to partners and payers.

3. State-by-State Laboratory Licensing

0 of 6 complete

All 50 states accept CLIA, but many additionally require their own license — you must hold each state's license before accepting orders from residents there.

4. Laboratory Director Requirements

0 of 5 complete

The director is legally accountable for test performance, validation, and result release.

5. HIPAA Compliance Program

0 of 6 complete

As a laboratory, you are a HIPAA covered entity (or business associate) handling PHI including genetic data.

6. Genetic Consent Requirements

0 of 5 complete

Genetic testing requires explicit, informed written consent — with extra protections beyond general medical consent.

7. Physician Ordering Model

0 of 5 complete

Most states require a physician order for clinical genetic testing — define the model before selling.

8. FDA / LDT Considerations

0 of 5 complete

A lab-developed test (LDT) is not FDA-approved — regulatory posture must be deliberate and claims disciplined.

9. Specimen Collection & Transport

0 of 5 complete

The kit and its journey are part of the regulated testing process.

10. Test Validation

0 of 5 complete

No patient results may be reported before validation is complete and director-approved.

11. Before Accepting Your First Paying Customer

0 of 7 complete

The final launch gate — every item here is a hard prerequisite.

Disclaimer: This checklist is an operational planning tool, not legal advice. Licensing, consent, and direct-access rules vary by state and change frequently — engage qualified healthcare regulatory counsel before launching testing services in any jurisdiction.